These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 11301060

  • 1. Release and aggregation of cytochrome c and alpha-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole.
    Kakimura J, Kitamura Y, Takata K, Kohno Y, Nomura Y, Taniguchi T.
    Eur J Pharmacol; 2001 Apr 06; 417(1-2):59-67. PubMed ID: 11301060
    [Abstract] [Full Text] [Related]

  • 2. Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells.
    Kitamura Y, Kosaka T, Kakimura JI, Matsuoka Y, Kohno Y, Nomura Y, Taniguchi T.
    Mol Pharmacol; 1998 Dec 06; 54(6):1046-54. PubMed ID: 9855633
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Increase of bcl-2 protein in neuronal dendritic processes of cerebral cortex and hippocampus by the antiparkinsonian drugs, talipexole and pramipexole.
    Takata K, Kitamura Y, Kakimura J, Kohno Y, Taniguchi T.
    Brain Res; 2000 Jul 28; 872(1-2):236-41. PubMed ID: 10924701
    [Abstract] [Full Text] [Related]

  • 8. MPP+ increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells.
    Gómez-Santos C, Ferrer I, Reiriz J, Viñals F, Barrachina M, Ambrosio S.
    Brain Res; 2002 May 10; 935(1-2):32-9. PubMed ID: 12062470
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease.
    Hashimoto M, Takeda A, Hsu LJ, Takenouchi T, Masliah E.
    J Biol Chem; 1999 Oct 08; 274(41):28849-52. PubMed ID: 10506125
    [Abstract] [Full Text] [Related]

  • 15. Decrease of prolactin secretion via stimulation of pituitary dopamine D-2 receptors after application of talipexole and SND 919.
    Domae M, Yamada K, Hanabusa Y, Matsumoto S, Furukawa T.
    Eur J Pharmacol; 1990 Apr 10; 179(1-2):75-82. PubMed ID: 2142088
    [Abstract] [Full Text] [Related]

  • 16. Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKCdelta and BAD to protect dopaminergic neuronal cells against MPP+-induced apoptotic cell death.
    Kaul S, Anantharam V, Kanthasamy A, Kanthasamy AG.
    Brain Res Mol Brain Res; 2005 Sep 13; 139(1):137-52. PubMed ID: 15978696
    [Abstract] [Full Text] [Related]

  • 17. Apoptosis induction by a dopaminergic neurotoxin, 1-methyl-4-phenylpyridinium ion (MPP(+)), and inhibition by epidermal growth factor in GH3 cells.
    Yoshinaga N, Murayama T, Nomura Y.
    Biochem Pharmacol; 2000 Jul 01; 60(1):111-20. PubMed ID: 10807952
    [Abstract] [Full Text] [Related]

  • 18. Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP-induced hemiparkinsonian monkeys.
    Domino EF, Ni L, Zhang H, Kohno Y, Sasa M.
    Eur J Pharmacol; 1997 May 01; 325(2-3):137-44. PubMed ID: 9163560
    [Abstract] [Full Text] [Related]

  • 19. Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis.
    Matsuyama S, Llopis J, Deveraux QL, Tsien RY, Reed JC.
    Nat Cell Biol; 2000 Jun 01; 2(6):318-25. PubMed ID: 10854321
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.